Pediatrix Medical Group (MD) Projected to Post Quarterly Earnings on Tuesday

Pediatrix Medical Group (NYSE:MD - Get Free Report) will likely be announcing its Q1 2025 earnings results before the market opens on Tuesday, May 6th. Analysts expect Pediatrix Medical Group to post earnings of $0.25 per share and revenue of $451.44 million for the quarter.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. The firm had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. On average, analysts expect Pediatrix Medical Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock traded up $0.20 during trading on Friday, hitting $12.94. 407,238 shares of the stock traded hands, compared to its average volume of 841,633. The stock has a market cap of $1.11 billion, a price-to-earnings ratio of -10.78, a PEG ratio of 1.74 and a beta of 1.32. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $17.67. The firm's fifty day moving average is $13.75 and its 200-day moving average is $13.98.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on MD. UBS Group boosted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Finally, Truist Financial lowered their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Pediatrix Medical Group currently has an average rating of "Hold" and an average target price of $16.75.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.